Accurate mass filtering of ion chromatograms for metabolite identification using a unit mass resolution liquid chromatography/mass spectrometry system

被引:25
作者
Gu, M
Wang, YD
Zhao, XG
Gu, ZM
机构
[1] Cerno Biosci, Monmouth Jct, NJ 08852 USA
[2] XenoBiot Labs, Plainsboro, NJ 08536 USA
关键词
D O I
10.1002/rcm.2377
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Acceleration of liquid chromatography/mass spectrometric (LC/MS) analysis for metabolite identification critically relies on effective data processing since the rate of data acquisition is much faster than the rate of data mining. The rapid and accurate identification of metabolite peaks from complex LC/MS data is a key component to speeding up the process. Current approaches routinely use selected ion chromatograms that can suffer severely from matrix effects. This paper describes a new method to automatically extract and filter metabolite-related information from LC/MS data obtained at unit mass resolution in the presence of complex biological matrices. This approach is illustrated by LC/MS analysis of the metabolites of verapamil from a rat microsome incubation spiked with biological matrix (bile). MS data were acquired in profile mode on a unit mass resolution triple-quadrupole instrument, externally calibrated using a unique procedure that corrects for both mass axis and mass spectral peak shape to facilitate metabolite identification with high mass accuracy. Through the double-filtering effects of accurate mass and isotope profile, conventional extracted ion chromatograms corresponding to the parent drug (verapamil at m/z 455), demethylated verapamil (m/z 441), and dealkylated verapamil (m/z 291), that contained substantial false-positive peaks, were simplified into chromatograms that are substantially free from matrix interferences. These filtered chromatograms approach what would have been obtained by using a radioactivity detector to detect radio-labeled metabolites of interest. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:764 / 770
页数:7
相关论文
共 16 条
[1]   Estimating the precision of exact mass measurements on an orthogonal time-of-flight mass spectrometer [J].
Blom, KF .
ANALYTICAL CHEMISTRY, 2001, 73 (03) :715-719
[2]   Verapamil - A review of its pharmacological properties and therapeutic use in coronary artery disease [J].
Brogden, RN ;
Benfield, P .
DRUGS, 1996, 51 (05) :792-819
[3]  
BUSCH KL, 1988, MASS SPECTROSCOPY MA
[4]   Systematic LC/MS metabolite identification in drug discovery [J].
Clarke, N ;
Rindgen, D ;
Korfmacher, W ;
Cox, K .
ANALYTICAL CHEMISTRY, 2001, 73 (15) :430A-439A
[5]   Using a triple-quadrupole mass spectrometer in accurate mass mode and an ion correlation program to identify compounds [J].
Grange, AH ;
Winnik, W ;
Ferguson, PL ;
Sovocool, GW .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (18) :2699-2715
[6]  
GU M, 2005, P 53 ASMS C MASS SPE
[7]  
GU M, 2005, SPECTROSCOPY MAY
[8]   Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry [J].
Kantharaj, E ;
Tuytelaars, A ;
Proost, PEA ;
Ongel, Z ;
van Assouw, HP ;
Gilissen, RAHJ .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (23) :2661-2668
[9]  
Korfmacher WA, 2005, USING MASS SPECTROMETRY FOR DRUG METABOLISM STUDIES, P1
[10]   VERAPAMIL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION [J].
MCTAVISH, D ;
SORKIN, EM .
DRUGS, 1989, 38 (01) :19-76